Investment
Features
FeesSafety
Academy
More
Pluang+

Compare TechnipFMC plc Ordinary Share (FTI) vs Novavax Inc (NVAX) Price & Performance

TechnipFMC plc Ordinary ShareTrade
Novavax IncTrade

Price performance (Past 24H)

Key statistics

TechnipFMC plc Ordinary Share vs Novavax Inc — how do they compare? TechnipFMC plc Ordinary Share trades at $69.99 (market cap $27.31B), while Novavax Inc trades at $11.1 (market cap $1.82B). The key difference: TechnipFMC plc Ordinary Share is far larger — about 15× Novavax Inc's market cap, and TechnipFMC plc Ordinary Share pays a 0.29% dividend while Novavax Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold TechnipFMC plc Ordinary Share for 0 Days and Novavax Inc for 59 Days on average.

FTINVAX
Market Cap
$27.31B$1.82B
Volume
2,496,4106,198,505
Sector
EnergyHealth
52-Week High
$80.08$12.56
52-Week Low
$35.57$6.22
Typical Hold Time
0 Days59 Days
Enterprise Value
$27.56B$1.39B
Dividend Yield
0.29%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

TechnipFMC plc Ordinary Share

No Aura AI signal available yet.

Novavax Inc

Novavax (NVAX) trades at $11.22, down 0.88% on the day, with a bullish technical signal from moving averages and strong analyst support (74% buy ratings). The company shows mixed fundamentals with a positive P/E of 3.14 and EV/EBITDA of 1.72, but negative net income margin of -59.87% and negative shareholder equity. Recent developments include regulatory approvals for its updated COVID-19 vaccine and strategic pivot toward Matrix-M adjuvant licensing partnerships.

The outlook remains speculative with significant execution risks in the transition from COVID vaccine dependency to partnership-driven model. While valuation metrics appear attractive and technical momentum is positive, persistent negative cash flows and competitive pressures in the biotech sector warrant caution. The stock presents high-risk, high-reward potential for investors comfortable with biotech volatility.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FTI
100% Buy0% Sell
Avg holding period · 0 Days
NVAX
59% Buy41% Sell
Avg holding period · 59 Days

Top news

Latest headlines on both assets

About TechnipFMC plc Ordinary Share

TechnipFMC is an energy technology company providing subsea systems, surface technologies, and related services across the life of oil and gas fields. Its offerings include equipment, controls, installation support, and digital tools for offshore and onshore projects.

Read more on FTI →

About Novavax Inc

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.

Read more on NVAX →